Comparative evaluation of the effectiveness and side effects of different ways of misoprostol Prescribed in the termination of the second trimester of pregnancy
Not Applicable
- Conditions
- Medical abortion.Medical abortion
- Registration Number
- IRCT2015123014333N47
- Lead Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
singleton pregnancy;gestational age 13 to 22 with an indication for termination of pregnancy in medical procedures; Chorioamnionitis.
Exclusion criteria: patients with a history of caesarean section; mother serious systemic and chronic disease , cardiovascular, renal diseases ; known sensitivity to prostaglandins and coagulopathy; uncontrolled seizure disorders; hemolytic disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ague. Timepoint: Baseline and 4 hours after drug administration. Method of measurement: By asking of patient.;Abdominal pain. Timepoint: Baseline and 4 hours after drug administration. Method of measurement: By asking of patient.;Nausea. Timepoint: Baseline and 4 hours after drug administration. Method of measurement: By asking of patient.;Vaginal bleeding. Timepoint: Baseline and 4 hours after drug administration. Method of measurement: By asking of patient and doctor observation.;Vomiting. Timepoint: Baseline and 4 hours after drug administration. Method of measurement: By asking of patient.;During the induction of abortion. Timepoint: From the intervention to discharge pregnancy products. Method of measurement: Based on clinical signs and doctor observation.
- Secondary Outcome Measures
Name Time Method